c capsid pucmini icap php eb Search Results


97
Addgene inc plasmid pucmini icap php eb encoding modified aav2 9 capsid
Plasmid Pucmini Icap Php Eb Encoding Modified Aav2 9 Capsid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2EeB+(Plasmid+%23103005)/pmc09277108-111-1-17
Average 97 stars, based on 1 article reviews
plasmid pucmini icap php eb encoding modified aav2 9 capsid - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

94
Addgene inc ad hoc capside plasmid
Ad Hoc Capside Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2ES+(Plasmid+%23103006)/bio_rxiv__2021__01__13__426492-200-32-42
Average 94 stars, based on 1 article reviews
ad hoc capside plasmid - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Addgene inc aav php v1 capsid
Aav Php V1 Capsid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2EV1+(Plasmid+%23127847)/pmc09882234-182-1-8
Average 93 stars, based on 1 article reviews
aav php v1 capsid - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

99
Thermo Fisher powerup sybr green master mix thermo fisher a46012 recombinant dna pucmini icap php eb plasmid
Powerup Sybr Green Master Mix Thermo Fisher A46012 Recombinant Dna Pucmini Icap Php Eb Plasmid, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/DNA/pm40403707-271-79-84
Average 99 stars, based on 1 article reviews
powerup sybr green master mix thermo fisher a46012 recombinant dna pucmini icap php eb plasmid - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

93
Addgene inc c critical three plasmids
C Critical Three Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pHelper+(Plasmid+%2385037)/10__1038_slash_s41596___018___0097___3-239-20-6
Average 93 stars, based on 1 article reviews
c critical three plasmids - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Addgene inc aav php b capsid
Aav Php B Capsid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2EB+(Plasmid+%23103002)/pmc08682997-252-6-13
Average 94 stars, based on 1 article reviews
aav php b capsid - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
VectorBuilder GmbH pucmini-icap-php.eb plasmid
Pucmini Icap Php.Eb Plasmid, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pucmini+icap+php+eb+plasmid/pmc09350993-107-20-43
Average 90 stars, based on 1 article reviews
pucmini-icap-php.eb plasmid - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Addgene inc aav php b4
A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of <t>AAV-PHP.V2</t> variant, described later, is mapped on this plot.
Aav Php B4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2EB4+(Plasmid+%23127849)/pmc07219404-212-17-7
Average 90 stars, based on 1 article reviews
aav php b4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Addgene inc aav php v2
A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of <t>AAV-PHP.V2</t> variant, described later, is mapped on this plot.
Aav Php V2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2EV2+(Plasmid+%23127848)/pmc07219404-212-15-7
Average 90 stars, based on 1 article reviews
aav php v2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Addgene inc pucmini icapphp n
A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of <t>AAV-PHP.V2</t> variant, described later, is mapped on this plot.
Pucmini Icapphp N, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pUCmini-iCAP-PHP%2EN+(Plasmid+%23127851)/pm41168169-158-17-18
Average 93 stars, based on 1 article reviews
pucmini icapphp n - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Blue Heron Biotech p δply
Streptococcus pneumoniae Strains, Plasmids, and Pneumolysin Codon-pair Bias
P δply, supplied by Blue Heron Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/p+%CE%B4ply/pmc03069727-68-173-140
Average 90 stars, based on 1 article reviews
p δply - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Blue Heron Biotech pucminus
Streptococcus pneumoniae Strains, Plasmids, and Pneumolysin Codon-pair Bias
Pucminus, supplied by Blue Heron Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+capsid+pucmini+icap+php+eb/pucminus/pmc03069727-68-184-140
Average 90 stars, based on 1 article reviews
pucminus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of AAV-PHP.V2 variant, described later, is mapped on this plot.

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of AAV-PHP.V2 variant, described later, is mapped on this plot.

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Selection, Sequencing, Variant Assay

Clustering analysis of positively enriched variants from Tek (left), GFAP (middle) and SNAP/Syn (right) synthetic pool brain libraries with size of nodes representing their relative enrichment in brain, and the thickness of edges (connecting lines) representing degree of relatedness. Distinct families (yellow) with the corresponding AA frequency logos (AA size represents prevalence and color encodes AA properties) are shown. b , The 7-mer insertion peptide sequences of AAV-PHP variants between AA positions 588–589 of AAV9 capsid are shown. AAs are colored by shared identity to AAV-PHP.B and eB (green) or among new variants (unique color per position). c , AAV9 (left) and AAV-PHP.V1 (right) mediated expression using ssAAV:CAG-mNeongreen genome (green, n = 3, 3 weeks of expression in C57BL/6J adult mice with 3×10 11 vg IV dose/mouse) is matched in fluorescence intensity in sagittal sections of brain (above) with higher magnification image from cortex (below). Magenta is αGLUT1 antibody staining for vasculature. d , Percentage of vasculature stained with αGLUT1 that overlaps with mNeongreen (XFP) expression in cortex. One-way ANOVA non-parametric Kruskal-Wallis test (P-value 0.0036), and follow-up multiple comparisons using uncorrected Dunn’s test (P-value of 0.0070 for AAV9 vs PHP.V1) are reported. **P ≤ 0.01 is shown, P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice per AAV variant, cells quantified from 4–2 images per mouse per cell-type. e , Percentage of cells stained with each cell-type specific marker (αGLUT1, αS100 for astrocytes, αNeuN for neurons, αOlig2 for oligodendrocyte lineage cells) that overlaps with mNeongreen (XFP) expression in cortex. Kruskal-Wallis test (P-value of 0.0078), and uncorrected Dunn’s test (P-value of 0.0235 for neuron vs vascular cells, and 0.0174 for neuron vs astrocyte, respectively) are reported. *P ≤ 0.05 is shown, and P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice, cells quantified from 4–2 images per mouse per cell-type. f , Vascular transduction by ssAAV-PHP.V1:CAG-DIO-EYFP in Tek-Cre adult mice (left) ( n = 2, 4 weeks of expression, 1×10 12 vg IV dose/mouse), and by ssAAV-PHP.V1:Ple261-iCre in Ai14 reporter mice (right) ( n = 2, 3 weeks of expression, 3×10 11 vg IV dose/mouse). Tissues are stained with αGLUT1 (magenta (left) and cyan (right)). g , Efficiency of vascular transduction (as described in d ) in Tek-Cre mice (n= 2, mean from 3 images per mouse per brain region). h , Efficiency of vascular transduction in Ai14 mice (n= 2, a mean from 4 images per mouse per brain region).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: Clustering analysis of positively enriched variants from Tek (left), GFAP (middle) and SNAP/Syn (right) synthetic pool brain libraries with size of nodes representing their relative enrichment in brain, and the thickness of edges (connecting lines) representing degree of relatedness. Distinct families (yellow) with the corresponding AA frequency logos (AA size represents prevalence and color encodes AA properties) are shown. b , The 7-mer insertion peptide sequences of AAV-PHP variants between AA positions 588–589 of AAV9 capsid are shown. AAs are colored by shared identity to AAV-PHP.B and eB (green) or among new variants (unique color per position). c , AAV9 (left) and AAV-PHP.V1 (right) mediated expression using ssAAV:CAG-mNeongreen genome (green, n = 3, 3 weeks of expression in C57BL/6J adult mice with 3×10 11 vg IV dose/mouse) is matched in fluorescence intensity in sagittal sections of brain (above) with higher magnification image from cortex (below). Magenta is αGLUT1 antibody staining for vasculature. d , Percentage of vasculature stained with αGLUT1 that overlaps with mNeongreen (XFP) expression in cortex. One-way ANOVA non-parametric Kruskal-Wallis test (P-value 0.0036), and follow-up multiple comparisons using uncorrected Dunn’s test (P-value of 0.0070 for AAV9 vs PHP.V1) are reported. **P ≤ 0.01 is shown, P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice per AAV variant, cells quantified from 4–2 images per mouse per cell-type. e , Percentage of cells stained with each cell-type specific marker (αGLUT1, αS100 for astrocytes, αNeuN for neurons, αOlig2 for oligodendrocyte lineage cells) that overlaps with mNeongreen (XFP) expression in cortex. Kruskal-Wallis test (P-value of 0.0078), and uncorrected Dunn’s test (P-value of 0.0235 for neuron vs vascular cells, and 0.0174 for neuron vs astrocyte, respectively) are reported. *P ≤ 0.05 is shown, and P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice, cells quantified from 4–2 images per mouse per cell-type. f , Vascular transduction by ssAAV-PHP.V1:CAG-DIO-EYFP in Tek-Cre adult mice (left) ( n = 2, 4 weeks of expression, 1×10 12 vg IV dose/mouse), and by ssAAV-PHP.V1:Ple261-iCre in Ai14 reporter mice (right) ( n = 2, 3 weeks of expression, 3×10 11 vg IV dose/mouse). Tissues are stained with αGLUT1 (magenta (left) and cyan (right)). g , Efficiency of vascular transduction (as described in d ) in Tek-Cre mice (n= 2, mean from 3 images per mouse per brain region). h , Efficiency of vascular transduction in Ai14 mice (n= 2, a mean from 4 images per mouse per brain region).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Expressing, Fluorescence, Staining, Variant Assay, Marker, Transduction

Transduction by AAV-PHP.B4–B6 and C1 variants, as well as B, eB, and AAV9 controls in sagittal brain and liver sections. Fluorescence intensity is matched with AAV-PHP.eB across each set of images (column-wise). The white box on the sagittal brain images marks the thalamus and not the precise region of the figures to the right. Vectors are packaged with ssAAV:CAG-2xNLS-EGFP genome ( n = 3 per group, 1×10 11 vg IV dose/adult C57BL/6J mouse, 3 weeks of expression). Tissues are stained with cell-type specific markers (magenta): αNeuN for neurons, αS100 for astrocytes and αOlig2 for oligodendrocyte lineage cells. Liver tissues are stained with a DNA stain, DAPI (blue). b , The percentage of αNeuN + , αS100 + and αOlig2 + cells with detectable nuclear-localized EGFP in the indicated brain regions are shown (n=3 per group, 1×10 11 vg dose). A two-way ANOVA with correction for multiple comparisons using Tukey’s test is reported with adjusted P-values (****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05, is shown, and P > 0.05 is not shown on the plot; 95% CI, data is mean ± S.E.M. The dataset comprises a mean of 2 images per region per cell-type marker per mouse).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: Transduction by AAV-PHP.B4–B6 and C1 variants, as well as B, eB, and AAV9 controls in sagittal brain and liver sections. Fluorescence intensity is matched with AAV-PHP.eB across each set of images (column-wise). The white box on the sagittal brain images marks the thalamus and not the precise region of the figures to the right. Vectors are packaged with ssAAV:CAG-2xNLS-EGFP genome ( n = 3 per group, 1×10 11 vg IV dose/adult C57BL/6J mouse, 3 weeks of expression). Tissues are stained with cell-type specific markers (magenta): αNeuN for neurons, αS100 for astrocytes and αOlig2 for oligodendrocyte lineage cells. Liver tissues are stained with a DNA stain, DAPI (blue). b , The percentage of αNeuN + , αS100 + and αOlig2 + cells with detectable nuclear-localized EGFP in the indicated brain regions are shown (n=3 per group, 1×10 11 vg dose). A two-way ANOVA with correction for multiple comparisons using Tukey’s test is reported with adjusted P-values (****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05, is shown, and P > 0.05 is not shown on the plot; 95% CI, data is mean ± S.E.M. The dataset comprises a mean of 2 images per region per cell-type marker per mouse).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Transduction, Fluorescence, Expressing, Staining, Marker

The design of the 3-mer-s PHP.B library with combinations of three AA diversification between AA 587–597 of AAV-PHP.B (or corresponding AA 587–590 of AAV9). Shared AA identity with the parent AAV-PHP.B (green) is shown along with unique motifs for AAV-PHP.N (pink) and AAV-PHP.eB (blue). b , Distributions of R2 brain and liver libraries (at AA level) by enrichment score (normalized to R2 virus library, with variants sorted in decreasing order of enrichment score). The enrichment of AAV-PHP.eB and AAV-PHP.N across all libraries are mapped on the plot. c , Heatmap represents the magnitude (log2 fold change) of a given AA’s relative enrichment or depletion at each position across the diversified region, only if statistical significance is reached on fold change (boxed if p-value ≤ 0.0001, two-sided, two-proportion z-test, p-values corrected for multiple comparisons using Bonferroni correction). Plot includes variants that were highly enriched in brain (>0.5 mean enrichment score, where mean is drawn across Vglut2, Vgat and GFAP, n = 1 library per mouse line (sample pooled from 2 mice per line)) and negatively enriched in liver (<0.0) (32 AA sequences). d , Clustering analysis of positively enriched variants from Vgat brain library is shown with node size representing the degree of negative enrichment in liver and the thickness of edges (connecting lines) representing degree of relatedness between nodes. Two distinct families are highlighted in yellow and their corresponding AA frequency logos are shown below (AA size represents prevalence and color encodes AA properties). e , The percentage of neurons, astrocytes and oligodendrocyte lineage cells with ssAAV-PHP.N:CAG-2xNLS-EGFP in the indicated brain regions is shown ( n = 3, 1×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression, data is mean±S.E.M, 6–8 images for cortex, thalamus and striatum, and 2 images for ventral midbrain, per mouse per cell-type marker using 20x objective covering the entire regions). A two-way ANOVA with correction for multiple comparisons using Tukey’s test gave adjusted P-values reported as ****P ≤ 0.0001, ns for P > 0.05, 95% CI. f , Transduction by ssAAV-PHP.N:CAG-NLS-EGFP ( n = 2, 2×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression) is shown with NeuN staining (magenta) across three brain areas (cortex, SNc (substantia nigra pars compacta) and thalamus).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: The design of the 3-mer-s PHP.B library with combinations of three AA diversification between AA 587–597 of AAV-PHP.B (or corresponding AA 587–590 of AAV9). Shared AA identity with the parent AAV-PHP.B (green) is shown along with unique motifs for AAV-PHP.N (pink) and AAV-PHP.eB (blue). b , Distributions of R2 brain and liver libraries (at AA level) by enrichment score (normalized to R2 virus library, with variants sorted in decreasing order of enrichment score). The enrichment of AAV-PHP.eB and AAV-PHP.N across all libraries are mapped on the plot. c , Heatmap represents the magnitude (log2 fold change) of a given AA’s relative enrichment or depletion at each position across the diversified region, only if statistical significance is reached on fold change (boxed if p-value ≤ 0.0001, two-sided, two-proportion z-test, p-values corrected for multiple comparisons using Bonferroni correction). Plot includes variants that were highly enriched in brain (>0.5 mean enrichment score, where mean is drawn across Vglut2, Vgat and GFAP, n = 1 library per mouse line (sample pooled from 2 mice per line)) and negatively enriched in liver (<0.0) (32 AA sequences). d , Clustering analysis of positively enriched variants from Vgat brain library is shown with node size representing the degree of negative enrichment in liver and the thickness of edges (connecting lines) representing degree of relatedness between nodes. Two distinct families are highlighted in yellow and their corresponding AA frequency logos are shown below (AA size represents prevalence and color encodes AA properties). e , The percentage of neurons, astrocytes and oligodendrocyte lineage cells with ssAAV-PHP.N:CAG-2xNLS-EGFP in the indicated brain regions is shown ( n = 3, 1×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression, data is mean±S.E.M, 6–8 images for cortex, thalamus and striatum, and 2 images for ventral midbrain, per mouse per cell-type marker using 20x objective covering the entire regions). A two-way ANOVA with correction for multiple comparisons using Tukey’s test gave adjusted P-values reported as ****P ≤ 0.0001, ns for P > 0.05, 95% CI. f , Transduction by ssAAV-PHP.N:CAG-NLS-EGFP ( n = 2, 2×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression) is shown with NeuN staining (magenta) across three brain areas (cortex, SNc (substantia nigra pars compacta) and thalamus).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: IF-P, Expressing, Marker, Transduction, Staining

Clustering analysis showing the brain-enriched sequence families of all variants described herein, either identified in prior studies (PHP.B-B3, PHP.eB) or in the current study (PHP.B4–B8, PHP.V1–2, PHP.C1–3). The thickness of edges (connecting lines) representing degree of relatedness between nodes. The AA sequences inserted between 588–589 (of AAV9 capsid) for all the variants discussed are shown below. b , Transduction of AAV9, AAV-PHP.V1 and AAV-PHP.N across three different mouse strains: C57BL/6J, BALB/cJ and FVB/NJ are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). c , Transduction by AAV-PHP.B, AAV-PHP.C1–C3 in C57BL/6J and BALB/cJ mice are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). b , c , The white box on the sagittal brain images represents the location of thalamus and not the precise area that is zoomed-in on the figure to the left. The fluorescence intensity is matched across all sagittal sections and across all thalamus regions acquired. The insets in AAV-PHP.V1 are zoom-ins with enhanced brightness. The indicated capsids were used to package ssAAV:CAG-mNeongreen ( n = 2–3 per group, 1×10 11 vg IV dose per 6–8 weeks old adult mouse, 3 weeks of expression. The data reported in b , c are from one independent trial where all viruses were freshly prepared and titered in the same assay for dosage consistency. AAV-PHP.C2 and AAV-PHP.C3 were further validated in an independent trial for BALB/cJ, n = 2 per group).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: Clustering analysis showing the brain-enriched sequence families of all variants described herein, either identified in prior studies (PHP.B-B3, PHP.eB) or in the current study (PHP.B4–B8, PHP.V1–2, PHP.C1–3). The thickness of edges (connecting lines) representing degree of relatedness between nodes. The AA sequences inserted between 588–589 (of AAV9 capsid) for all the variants discussed are shown below. b , Transduction of AAV9, AAV-PHP.V1 and AAV-PHP.N across three different mouse strains: C57BL/6J, BALB/cJ and FVB/NJ are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). c , Transduction by AAV-PHP.B, AAV-PHP.C1–C3 in C57BL/6J and BALB/cJ mice are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). b , c , The white box on the sagittal brain images represents the location of thalamus and not the precise area that is zoomed-in on the figure to the left. The fluorescence intensity is matched across all sagittal sections and across all thalamus regions acquired. The insets in AAV-PHP.V1 are zoom-ins with enhanced brightness. The indicated capsids were used to package ssAAV:CAG-mNeongreen ( n = 2–3 per group, 1×10 11 vg IV dose per 6–8 weeks old adult mouse, 3 weeks of expression. The data reported in b , c are from one independent trial where all viruses were freshly prepared and titered in the same assay for dosage consistency. AAV-PHP.C2 and AAV-PHP.C3 were further validated in an independent trial for BALB/cJ, n = 2 per group).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Sequencing, Transduction, Fluorescence, Expressing

A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of AAV-PHP.V2 variant, described later, is mapped on this plot.

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: A multiplexed selection approach to identify capsids with specific and broad tropisms. Steps 1–6 describe the workflow in Round-1 (R1) selection, steps 7–9 describe Round-2 (R2) selection using synthetic pool method, steps 1a, 2a, and 6a-b show the incorporation of deep sequencing to recover capsids after R1 and R2 selection, and steps 10–11 describe positive and/or negative selection criteria followed by variant characterization. b , Structural model of the AAV9 capsid (PDB 3UX1) with the insertion site for the 7-mer-i library highlighted in red in the 60-meric (left), trimeric (middle), and monomeric (right) forms. c , Empirical Cumulative Distribution Frequency (ECDF) of R1 DNA and virus libraries that were recovered by deep sequencing post Gibson assembly and virus production, respectively. d , Distributions of variants recovered from three R1 brain tissue libraries, Tek, SNAP25, and GFAP (n = 2 per Cre line), are shown with capsid libraries sorted by decreasing order of the enrichment score. The enrichment score of AAV-PHP.V2 variant, described later, is mapped on this plot.

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Selection, Sequencing, Variant Assay

Clustering analysis of positively enriched variants from Tek (left), GFAP (middle) and SNAP/Syn (right) synthetic pool brain libraries with size of nodes representing their relative enrichment in brain, and the thickness of edges (connecting lines) representing degree of relatedness. Distinct families (yellow) with the corresponding AA frequency logos (AA size represents prevalence and color encodes AA properties) are shown. b , The 7-mer insertion peptide sequences of AAV-PHP variants between AA positions 588–589 of AAV9 capsid are shown. AAs are colored by shared identity to AAV-PHP.B and eB (green) or among new variants (unique color per position). c , AAV9 (left) and AAV-PHP.V1 (right) mediated expression using ssAAV:CAG-mNeongreen genome (green, n = 3, 3 weeks of expression in C57BL/6J adult mice with 3×10 11 vg IV dose/mouse) is matched in fluorescence intensity in sagittal sections of brain (above) with higher magnification image from cortex (below). Magenta is αGLUT1 antibody staining for vasculature. d , Percentage of vasculature stained with αGLUT1 that overlaps with mNeongreen (XFP) expression in cortex. One-way ANOVA non-parametric Kruskal-Wallis test (P-value 0.0036), and follow-up multiple comparisons using uncorrected Dunn’s test (P-value of 0.0070 for AAV9 vs PHP.V1) are reported. **P ≤ 0.01 is shown, P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice per AAV variant, cells quantified from 4–2 images per mouse per cell-type. e , Percentage of cells stained with each cell-type specific marker (αGLUT1, αS100 for astrocytes, αNeuN for neurons, αOlig2 for oligodendrocyte lineage cells) that overlaps with mNeongreen (XFP) expression in cortex. Kruskal-Wallis test (P-value of 0.0078), and uncorrected Dunn’s test (P-value of 0.0235 for neuron vs vascular cells, and 0.0174 for neuron vs astrocyte, respectively) are reported. *P ≤ 0.05 is shown, and P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice, cells quantified from 4–2 images per mouse per cell-type. f , Vascular transduction by ssAAV-PHP.V1:CAG-DIO-EYFP in Tek-Cre adult mice (left) ( n = 2, 4 weeks of expression, 1×10 12 vg IV dose/mouse), and by ssAAV-PHP.V1:Ple261-iCre in Ai14 reporter mice (right) ( n = 2, 3 weeks of expression, 3×10 11 vg IV dose/mouse). Tissues are stained with αGLUT1 (magenta (left) and cyan (right)). g , Efficiency of vascular transduction (as described in d ) in Tek-Cre mice (n= 2, mean from 3 images per mouse per brain region). h , Efficiency of vascular transduction in Ai14 mice (n= 2, a mean from 4 images per mouse per brain region).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: Clustering analysis of positively enriched variants from Tek (left), GFAP (middle) and SNAP/Syn (right) synthetic pool brain libraries with size of nodes representing their relative enrichment in brain, and the thickness of edges (connecting lines) representing degree of relatedness. Distinct families (yellow) with the corresponding AA frequency logos (AA size represents prevalence and color encodes AA properties) are shown. b , The 7-mer insertion peptide sequences of AAV-PHP variants between AA positions 588–589 of AAV9 capsid are shown. AAs are colored by shared identity to AAV-PHP.B and eB (green) or among new variants (unique color per position). c , AAV9 (left) and AAV-PHP.V1 (right) mediated expression using ssAAV:CAG-mNeongreen genome (green, n = 3, 3 weeks of expression in C57BL/6J adult mice with 3×10 11 vg IV dose/mouse) is matched in fluorescence intensity in sagittal sections of brain (above) with higher magnification image from cortex (below). Magenta is αGLUT1 antibody staining for vasculature. d , Percentage of vasculature stained with αGLUT1 that overlaps with mNeongreen (XFP) expression in cortex. One-way ANOVA non-parametric Kruskal-Wallis test (P-value 0.0036), and follow-up multiple comparisons using uncorrected Dunn’s test (P-value of 0.0070 for AAV9 vs PHP.V1) are reported. **P ≤ 0.01 is shown, P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice per AAV variant, cells quantified from 4–2 images per mouse per cell-type. e , Percentage of cells stained with each cell-type specific marker (αGLUT1, αS100 for astrocytes, αNeuN for neurons, αOlig2 for oligodendrocyte lineage cells) that overlaps with mNeongreen (XFP) expression in cortex. Kruskal-Wallis test (P-value of 0.0078), and uncorrected Dunn’s test (P-value of 0.0235 for neuron vs vascular cells, and 0.0174 for neuron vs astrocyte, respectively) are reported. *P ≤ 0.05 is shown, and P > 0.05 is not shown; data is mean ± S.E.M, n= 3 mice, cells quantified from 4–2 images per mouse per cell-type. f , Vascular transduction by ssAAV-PHP.V1:CAG-DIO-EYFP in Tek-Cre adult mice (left) ( n = 2, 4 weeks of expression, 1×10 12 vg IV dose/mouse), and by ssAAV-PHP.V1:Ple261-iCre in Ai14 reporter mice (right) ( n = 2, 3 weeks of expression, 3×10 11 vg IV dose/mouse). Tissues are stained with αGLUT1 (magenta (left) and cyan (right)). g , Efficiency of vascular transduction (as described in d ) in Tek-Cre mice (n= 2, mean from 3 images per mouse per brain region). h , Efficiency of vascular transduction in Ai14 mice (n= 2, a mean from 4 images per mouse per brain region).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Expressing, Fluorescence, Staining, Variant Assay, Marker, Transduction

Transduction by AAV-PHP.B4–B6 and C1 variants, as well as B, eB, and AAV9 controls in sagittal brain and liver sections. Fluorescence intensity is matched with AAV-PHP.eB across each set of images (column-wise). The white box on the sagittal brain images marks the thalamus and not the precise region of the figures to the right. Vectors are packaged with ssAAV:CAG-2xNLS-EGFP genome ( n = 3 per group, 1×10 11 vg IV dose/adult C57BL/6J mouse, 3 weeks of expression). Tissues are stained with cell-type specific markers (magenta): αNeuN for neurons, αS100 for astrocytes and αOlig2 for oligodendrocyte lineage cells. Liver tissues are stained with a DNA stain, DAPI (blue). b , The percentage of αNeuN + , αS100 + and αOlig2 + cells with detectable nuclear-localized EGFP in the indicated brain regions are shown (n=3 per group, 1×10 11 vg dose). A two-way ANOVA with correction for multiple comparisons using Tukey’s test is reported with adjusted P-values (****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05, is shown, and P > 0.05 is not shown on the plot; 95% CI, data is mean ± S.E.M. The dataset comprises a mean of 2 images per region per cell-type marker per mouse).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: Transduction by AAV-PHP.B4–B6 and C1 variants, as well as B, eB, and AAV9 controls in sagittal brain and liver sections. Fluorescence intensity is matched with AAV-PHP.eB across each set of images (column-wise). The white box on the sagittal brain images marks the thalamus and not the precise region of the figures to the right. Vectors are packaged with ssAAV:CAG-2xNLS-EGFP genome ( n = 3 per group, 1×10 11 vg IV dose/adult C57BL/6J mouse, 3 weeks of expression). Tissues are stained with cell-type specific markers (magenta): αNeuN for neurons, αS100 for astrocytes and αOlig2 for oligodendrocyte lineage cells. Liver tissues are stained with a DNA stain, DAPI (blue). b , The percentage of αNeuN + , αS100 + and αOlig2 + cells with detectable nuclear-localized EGFP in the indicated brain regions are shown (n=3 per group, 1×10 11 vg dose). A two-way ANOVA with correction for multiple comparisons using Tukey’s test is reported with adjusted P-values (****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05, is shown, and P > 0.05 is not shown on the plot; 95% CI, data is mean ± S.E.M. The dataset comprises a mean of 2 images per region per cell-type marker per mouse).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Transduction, Fluorescence, Expressing, Staining, Marker

The design of the 3-mer-s PHP.B library with combinations of three AA diversification between AA 587–597 of AAV-PHP.B (or corresponding AA 587–590 of AAV9). Shared AA identity with the parent AAV-PHP.B (green) is shown along with unique motifs for AAV-PHP.N (pink) and AAV-PHP.eB (blue). b , Distributions of R2 brain and liver libraries (at AA level) by enrichment score (normalized to R2 virus library, with variants sorted in decreasing order of enrichment score). The enrichment of AAV-PHP.eB and AAV-PHP.N across all libraries are mapped on the plot. c , Heatmap represents the magnitude (log2 fold change) of a given AA’s relative enrichment or depletion at each position across the diversified region, only if statistical significance is reached on fold change (boxed if p-value ≤ 0.0001, two-sided, two-proportion z-test, p-values corrected for multiple comparisons using Bonferroni correction). Plot includes variants that were highly enriched in brain (>0.5 mean enrichment score, where mean is drawn across Vglut2, Vgat and GFAP, n = 1 library per mouse line (sample pooled from 2 mice per line)) and negatively enriched in liver (<0.0) (32 AA sequences). d , Clustering analysis of positively enriched variants from Vgat brain library is shown with node size representing the degree of negative enrichment in liver and the thickness of edges (connecting lines) representing degree of relatedness between nodes. Two distinct families are highlighted in yellow and their corresponding AA frequency logos are shown below (AA size represents prevalence and color encodes AA properties). e , The percentage of neurons, astrocytes and oligodendrocyte lineage cells with ssAAV-PHP.N:CAG-2xNLS-EGFP in the indicated brain regions is shown ( n = 3, 1×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression, data is mean±S.E.M, 6–8 images for cortex, thalamus and striatum, and 2 images for ventral midbrain, per mouse per cell-type marker using 20x objective covering the entire regions). A two-way ANOVA with correction for multiple comparisons using Tukey’s test gave adjusted P-values reported as ****P ≤ 0.0001, ns for P > 0.05, 95% CI. f , Transduction by ssAAV-PHP.N:CAG-NLS-EGFP ( n = 2, 2×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression) is shown with NeuN staining (magenta) across three brain areas (cortex, SNc (substantia nigra pars compacta) and thalamus).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: The design of the 3-mer-s PHP.B library with combinations of three AA diversification between AA 587–597 of AAV-PHP.B (or corresponding AA 587–590 of AAV9). Shared AA identity with the parent AAV-PHP.B (green) is shown along with unique motifs for AAV-PHP.N (pink) and AAV-PHP.eB (blue). b , Distributions of R2 brain and liver libraries (at AA level) by enrichment score (normalized to R2 virus library, with variants sorted in decreasing order of enrichment score). The enrichment of AAV-PHP.eB and AAV-PHP.N across all libraries are mapped on the plot. c , Heatmap represents the magnitude (log2 fold change) of a given AA’s relative enrichment or depletion at each position across the diversified region, only if statistical significance is reached on fold change (boxed if p-value ≤ 0.0001, two-sided, two-proportion z-test, p-values corrected for multiple comparisons using Bonferroni correction). Plot includes variants that were highly enriched in brain (>0.5 mean enrichment score, where mean is drawn across Vglut2, Vgat and GFAP, n = 1 library per mouse line (sample pooled from 2 mice per line)) and negatively enriched in liver (<0.0) (32 AA sequences). d , Clustering analysis of positively enriched variants from Vgat brain library is shown with node size representing the degree of negative enrichment in liver and the thickness of edges (connecting lines) representing degree of relatedness between nodes. Two distinct families are highlighted in yellow and their corresponding AA frequency logos are shown below (AA size represents prevalence and color encodes AA properties). e , The percentage of neurons, astrocytes and oligodendrocyte lineage cells with ssAAV-PHP.N:CAG-2xNLS-EGFP in the indicated brain regions is shown ( n = 3, 1×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression, data is mean±S.E.M, 6–8 images for cortex, thalamus and striatum, and 2 images for ventral midbrain, per mouse per cell-type marker using 20x objective covering the entire regions). A two-way ANOVA with correction for multiple comparisons using Tukey’s test gave adjusted P-values reported as ****P ≤ 0.0001, ns for P > 0.05, 95% CI. f , Transduction by ssAAV-PHP.N:CAG-NLS-EGFP ( n = 2, 2×10 11 vg IV dose per adult C57BL/6J mouse, 3 weeks of expression) is shown with NeuN staining (magenta) across three brain areas (cortex, SNc (substantia nigra pars compacta) and thalamus).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: IF-P, Expressing, Marker, Transduction, Staining

Clustering analysis showing the brain-enriched sequence families of all variants described herein, either identified in prior studies (PHP.B-B3, PHP.eB) or in the current study (PHP.B4–B8, PHP.V1–2, PHP.C1–3). The thickness of edges (connecting lines) representing degree of relatedness between nodes. The AA sequences inserted between 588–589 (of AAV9 capsid) for all the variants discussed are shown below. b , Transduction of AAV9, AAV-PHP.V1 and AAV-PHP.N across three different mouse strains: C57BL/6J, BALB/cJ and FVB/NJ are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). c , Transduction by AAV-PHP.B, AAV-PHP.C1–C3 in C57BL/6J and BALB/cJ mice are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). b , c , The white box on the sagittal brain images represents the location of thalamus and not the precise area that is zoomed-in on the figure to the left. The fluorescence intensity is matched across all sagittal sections and across all thalamus regions acquired. The insets in AAV-PHP.V1 are zoom-ins with enhanced brightness. The indicated capsids were used to package ssAAV:CAG-mNeongreen ( n = 2–3 per group, 1×10 11 vg IV dose per 6–8 weeks old adult mouse, 3 weeks of expression. The data reported in b , c are from one independent trial where all viruses were freshly prepared and titered in the same assay for dosage consistency. AAV-PHP.C2 and AAV-PHP.C3 were further validated in an independent trial for BALB/cJ, n = 2 per group).

Journal: Nature methods

Article Title: Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types

doi: 10.1038/s41592-020-0799-7

Figure Lengend Snippet: Clustering analysis showing the brain-enriched sequence families of all variants described herein, either identified in prior studies (PHP.B-B3, PHP.eB) or in the current study (PHP.B4–B8, PHP.V1–2, PHP.C1–3). The thickness of edges (connecting lines) representing degree of relatedness between nodes. The AA sequences inserted between 588–589 (of AAV9 capsid) for all the variants discussed are shown below. b , Transduction of AAV9, AAV-PHP.V1 and AAV-PHP.N across three different mouse strains: C57BL/6J, BALB/cJ and FVB/NJ are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). c , Transduction by AAV-PHP.B, AAV-PHP.C1–C3 in C57BL/6J and BALB/cJ mice are shown in sagittal brain sections (right), along with a higher magnification image of the thalamus brain region (left). b , c , The white box on the sagittal brain images represents the location of thalamus and not the precise area that is zoomed-in on the figure to the left. The fluorescence intensity is matched across all sagittal sections and across all thalamus regions acquired. The insets in AAV-PHP.V1 are zoom-ins with enhanced brightness. The indicated capsids were used to package ssAAV:CAG-mNeongreen ( n = 2–3 per group, 1×10 11 vg IV dose per 6–8 weeks old adult mouse, 3 weeks of expression. The data reported in b , c are from one independent trial where all viruses were freshly prepared and titered in the same assay for dosage consistency. AAV-PHP.C2 and AAV-PHP.C3 were further validated in an independent trial for BALB/cJ, n = 2 per group).

Article Snippet: The following vector plasmids are deposited on Addgene for distribution ( http://www.addgene.org ) AAV-PHP.V1: 127847, AAV-PHP.V2: 127848, AAV-PHP.B4: 127849, and AAV-PHP.N: 127851.

Techniques: Sequencing, Transduction, Fluorescence, Expressing

Streptococcus pneumoniae Strains, Plasmids, and Pneumolysin Codon-pair Bias

Journal: The Journal of Infectious Diseases

Article Title: Designed Reduction of Streptococcus pneumoniae Pathogenicity via Synthetic Changes in Virulence Factor Codon-pair Bias

doi: 10.1093/infdis/jir010

Figure Lengend Snippet: Streptococcus pneumoniae Strains, Plasmids, and Pneumolysin Codon-pair Bias

Article Snippet: Single colonies were inoculated into 15 mL of tryptic-soy broth (TSB) and grown at 37°C with .5% carbon dioxide (CO 2 ) for 15 h, and then diluted 1:100 in TSB or Todd-Hewitt broth (THB) and grown at 37°C with .5% CO 2 . table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 S. pneumoniae strain or plasmid Genotype, description, or codon-pair bias value Source, reference, or no. of nucleotide changes S. pneumoniae strains A66.1 Serotype 3 S. pneumoniae [ 17 ] A66.1:PM2 A66.1; synthetically modified pneumolysin via transformation with pPM2, Km r This study A66.1:PM4 A66.1; synthetically modified pneumolysin via transformation with pPM4, Km r This study A66.1:Δ ply A66.1; Δ ply via transformation with p ΔPLY, Km r This study A66.1:: ply A66.1; reconstituted ply via transformation with pPLY, Km r This study Plasmids pUCminus Synthetic carrier plasmid Blue Heron Biotechnology pPM4 Derivative of pUCminus that contains synthetic construct pPM4 ( ) This study pPM2 Derivative of pUCminus that contains synthetic construct pPM2 ( ) This study p ΔPLY Derivative of pUCminus that contains synthetic construct p ΔPLYThis study pPLY Derivative of pUCminus that contains the wild-type pneumolysin and Km r cassette (not shown) This study Strain (pneumolysin) A66.1 ( ply ) .095 ... A66:PM2 ( ply −.19 ) −.194 a 275 b A66:PM4 ( ply −.47 ) −.472 a 360 b Open in a separate window NOTE.

Techniques: Modification, Transformation Assay, Plasmid Preparation, Construct

Streptococcus pneumoniae Strains, Plasmids, and Pneumolysin Codon-pair Bias

Journal: The Journal of Infectious Diseases

Article Title: Designed Reduction of Streptococcus pneumoniae Pathogenicity via Synthetic Changes in Virulence Factor Codon-pair Bias

doi: 10.1093/infdis/jir010

Figure Lengend Snippet: Streptococcus pneumoniae Strains, Plasmids, and Pneumolysin Codon-pair Bias

Article Snippet: Single colonies were inoculated into 15 mL of tryptic-soy broth (TSB) and grown at 37°C with .5% carbon dioxide (CO 2 ) for 15 h, and then diluted 1:100 in TSB or Todd-Hewitt broth (THB) and grown at 37°C with .5% CO 2 . table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 S. pneumoniae strain or plasmid Genotype, description, or codon-pair bias value Source, reference, or no. of nucleotide changes S. pneumoniae strains A66.1 Serotype 3 S. pneumoniae [ 17 ] A66.1:PM2 A66.1; synthetically modified pneumolysin via transformation with pPM2, Km r This study A66.1:PM4 A66.1; synthetically modified pneumolysin via transformation with pPM4, Km r This study A66.1:Δ ply A66.1; Δ ply via transformation with p ΔPLY, Km r This study A66.1:: ply A66.1; reconstituted ply via transformation with pPLY, Km r This study Plasmids pUCminus Synthetic carrier plasmid Blue Heron Biotechnology pPM4 Derivative of pUCminus that contains synthetic construct pPM4 ( ) This study pPM2 Derivative of pUCminus that contains synthetic construct pPM2 ( ) This study p ΔPLY Derivative of pUCminus that contains synthetic construct p ΔPLYThis study pPLY Derivative of pUCminus that contains the wild-type pneumolysin and Km r cassette (not shown) This study Strain (pneumolysin) A66.1 ( ply ) .095 ... A66:PM2 ( ply −.19 ) −.194 a 275 b A66:PM4 ( ply −.47 ) −.472 a 360 b Open in a separate window NOTE.

Techniques: Modification, Transformation Assay, Plasmid Preparation, Construct